Clinical trial
Humoral Determinants of Immunity to Pneumococcal Infection
NCT00304382 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00304382 |
|---|---|
| Title | Humoral Determinants of Immunity to Pneumococcal Infection |
| Official title | Humoral Determinants of Immunity to Pneumococcal Infection |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Collaborators | Michael E. DeBakey VA Medical Center U.S. Fed |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pneumonia, Pneumococcal Infections, Infections, Streptococcus Pneumoniae |
| Intervention type | Biological |
| Interventions | Prevnar, Pneumovax |
| Enrollment | 114 |
| Start date | Jan 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Jun 1, 2012 |
| First posted | Mar 17, 2006 |
| Last update posted | Sep 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: